发明名称 5-hydroxy-4-(trifluoromethyl)pyrazolopyridine derivative
摘要 A compound which has excellent LCAT activation effects, is useful as an active ingredient of a therapeutic or preventive agent for arteriosclerosis, arteriosclerotic cardiovascular disease, coronary heart disease (including heart failure, myocardial infarction, angina, cardiac ischemia, cardiovascular disorder, and angioplastic restenosis), cerebrovascular disease (including cerebral stroke and cerebral infarction), peripheral vascular disease (including diabetic vascular complication), dyslipidemia, low HDL cholesterol, high HDL cholesterol, or kidney disease, in particular, of an anti-arteriosclerosis agent, and is represented by general formula (I) (I) [In the formula, R is an aryl group which may be substituted or a heteroaryl group which may be substituted, and R
申请公布号 AU2014362144(A2) 申请公布日期 2016.07.14
申请号 AU20140362144 申请日期 2014.12.12
申请人 DAIICHI SANKYO COMPANY, LIMITED 发明人 KOBAYASHI, HIDEKI;ARAI, MASAMI;KANEKO, TOSHIO;TERASAKA, NAOKI
分类号 C07D471/04;A61K31/4545;A61K31/497;A61K31/501;A61K31/506;A61P3/06;A61P9/04;A61P9/10;A61P13/12;A61P43/00 主分类号 C07D471/04
代理机构 代理人
主权项
地址